Senate debates
Monday, 21 November 2016
Committees
Community Affairs References Committee; Reference
4:53 pm
Stirling Griff (SA, Nick Xenophon Team) Share this | Hansard source
I seek leave to amend business of the Senate notice of motion No. 4 standing in my name and in the name of Senator Xenophon for today proposing a reference to the Senate Community Affairs References Committee relating to the prostheses list framework.
Leave granted.
I move the motion as amended:
That the following matters be referred to the Community Affairs References Committee for inquiry and report by 20 30 March 2017:
Price regulation associated with the Prostheses List Framework, with particular reference to:
(a) the operation of relevant legislative and regulatory instruments;
(b) opportunities for creating a more competitive basis for the purchase and reimbursement of prostheses;
(c) the role and function of the Prostheses List Advisory Committee (PLAC) and its subcommittees;
(d) the cost of medical devices and prostheses for privately insured patients versus public hospital patients and patients in other countries;
(e) the impact the current Prostheses List Framework has on the affordability of private health insurance in Australia;
(f) the benefits of reforming the reference pricing system with Australian and international benchmarks;
(g) the benefits of any other pricing mechanism arrangements, including but not limited to those adopted by the Pharmaceutical Benefits Scheme, such as:
(i) mandatory price disclosure,
(ii) value-based pricing, and
(iii) reference pricing;
(h) price data and analytics to reveal the extent of and where costs are being generated within the supply chain, with a particular focus on the device categories of cardiac, Intra Ocular Lens Systems (IOLS), hips, knees, spine and trauma;
(i) any interactions between Government decision-making and device manufacturers or stakeholders and their lobbyists;
(j) any implications for prostheses recipients of the NDIS transition period; and
(k) any other related matters.
No comments